HURA (STOCKS)
TuHURA Biosciences, Inc. Common Stock
$2.860000
+0.590000 (+25.99%)
Prev close: $2.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James A. Bianco
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $181.83M
- Employees
- 19
- P/E (TTM)
- -3.60
- P/B (TTM)
- 6.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.13 | $-0.15 | +0.0230 | +15.03% |
|
Jun 2025 (Q2)
|
$-0.21 | $-0.13 | -0.0808 | -62.54% |
|
Mar 2025 (Q1)
|
$-0.15 | $-0.10 | -0.0480 | -47.06% |
|
Sep 2023 (Q1)
|
$-1.83 | $-0.59 | -1.2384 | -209.33% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $31.80M |
| Research and Development | $20.53M |
| Other Operating Expenses | $11.26M |
| Income/Loss From Continuing Operations After Tax | -$30.05M |
| Income/Loss From Continuing Operations Before Tax | -$30.05M |
| Income Tax Expense/Benefit | $1.60K |
| Income Tax Expense/Benefit, Current | $1.60K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Expense, Operating | $625.28K |
| Net Income/Loss | -$30.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$30.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $8.36K |
| Preferred Stock Dividends And Other Adjustments | $8.36K |
| Basic Earnings Per Share | -$0.63 |
| Diluted Earnings Per Share | -$0.63 |
| Basic Average Shares | 47,927,196 |
| Diluted Average Shares | 47,927,196 |
| Assets | $27.35M |
| Current Assets | $4.62M |
| Noncurrent Assets | $22.73M |
| Fixed Assets | $300.64K |
| Other Non-current Assets | $22.43M |
| Liabilities | $6.42M |
| Current Liabilities | $5.92M |
| Accounts Payable | $3.77M |
| Other Current Liabilities | $2.15M |
| Noncurrent Liabilities | $501.55K |
| Equity | $20.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.93M |
| Liabilities And Equity | $27.35M |
| Net Cash Flow From Operating Activities | -$27.63M |
| Net Cash Flow From Operating Activities, Continuing | -$27.63M |
| Net Cash Flow From Investing Activities | -$1.34M |
| Net Cash Flow From Investing Activities, Continuing | -$1.34M |
| Net Cash Flow From Financing Activities | $19.93M |
| Net Cash Flow From Financing Activities, Continuing | $19.93M |
| Net Cash Flow | -$9.04M |
| Net Cash Flow, Continuing | -$9.04M |
| Comprehensive Income/Loss | -$30.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.05M |
| Other Comprehensive Income/Loss | $0.00 |